Privium Fund Management B.V. Pro Qr Therapeutics N.V. Call Options Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRQR
# of Institutions
63Shares Held
18.6MCall Options Held
37.7KPut Options Held
21.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.61 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.84MShares$3.86 Million0.14% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.54MShares$3.23 Million0.25% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$2.14 Million1.76% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA906KShares$1.9 Million0.42% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $150M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...